Suven Life Sciences Limited

Web: suven.com NSE: SUVEN BSE: 530239 SECTOR: Healthcare - Healthcare Services | Add Note | View Notes

277 13(-5%)

Volume

16L as on 23, Jun

Open

132

High

138

Low

131

290

VWAP

263

52 Week High

403

52 Week Low

124

Viand Research Rating

Quality Score

28/100

Growth Score

31/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

7,840

No. of Shares

28.3

P/E

-104.53

P/B

3.29

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

-3.15

ROCE

Profit Growth

Listing Date

23-Oct-03

Rank/Sector Rank

#648/#61

Promoter Holding

65.47%

FII Holding

0.48%

DII Holding

2.73%

Price Chart

Price Performance

1 Week4%

1 Month3%

3 Months104%

6 Months79%

1 Year79%

YTD79%

Moving Average

5 Day SMA263

10 Day SMA265

20 Day SMA265

30 Day SMA258

50 Day SMA238

61 Day SMA222

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	288	269	283	286
Resistance 2	283	268	277	282
Resistance 1	274	266	274	272
Pivot Point	268	265	268	268
Support 1	260	264	263	258
Support 2	254	262	260	253
Support 3	246	261	254	244

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,18,698	1745	0%	5%	4%	4%	37	55.5	0.07	11509
2	DIVISLAB	2,43,966	9190	2%	0%	45%	38%	69	55.5	0	2568
3	TORNTPHARM	1,73,208	4554	2%	5%	10%	28%	72	55.5	1.79	2138
4	ZYDUSLIFE	1,11,451	1117	0%	1%	20%	12%	20	55.5	0.31	3560
5	APOLLOHOSP	1,09,276	7600	2%	9%	4%	1%	58	55.5	0.9	2003
6	LAURUSLABS	1,08,738	2012	1%	8%	83%	124%	0	55.5	0.48	890
7	CIPLA	1,06,154	1314	2%	2%	8%	19%	22	55.5	0.02	3862
8	DRREDDY	1,03,873	1244	3%	8%	1%	4%	20	55.5	0.2	4158
9	MANKIND	94,401	2286	4%	1%	8%	7%	49	55.5	0.39	1938
10	AUROPHARMA	90,841	1579	2%	1%	20%	52%	0	55.5	0.19	2415
Load More

Shareholding Pattern (%)

	Jul 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jul 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(-4.61) 65.47%	(-0.11) 70.08%	(2.81) 70.15%	(0.01) 67.36%	(-0.11) 67.36%	(-2.81) 67.42%	(0.01) 70.26%	(0.01) 70.26%	(0.01) 70.26%	(0.01) 70.26%	(0.71) 70.26%	(0.01) 69.56%	(0.01) 69.56%	(0.01) 69.56%	(0.01) 69.56%	(0.01) 69.56%	(4.61) 69.56%	(0.01) 64.98%	(0.01) 64.98%	(5.01) 64.98%	(0.01) 60.00%	(0.01) 60.00%
FIIs	(-0.11) 0.48%	(-0.41) 0.56%	(-0.21) 0.91%	(-0.11) 1.07%	(0.61) 1.17%	(0.01) 0.56%	(0.31) 0.58%	(-0.11) 0.25%	(0.01) 0.34%	(-0.11) 0.33%	(0.01) 0.45%	(-0.11) 0.46%	(0.01) 0.54%	(0.01) 0.50%	(0.01) 0.48%	(0.11) 0.51%	(0.01) 0.46%	(0.01) 0.48%	(0.01) 0.45%	(-0.11) 0.45%	(0.11) 0.52%	(0.01) 0.44%
DIIs	(-0.21) 2.73%	(-1.71) 2.93%	(1.21) 4.62%	(0.01) 3.39%	(0.01) 3.39%	(3.41) 3.41%	(0.01) 0.03%	(-1.01) 0.01%	(0.01) 1.05%	(0.01) 1.05%	(0.01) 1.05%	(1.01) 1.05%	(0.01) 0.01%	(-0.11) 0.01%	(0.01) 0.08%	(0.01) 0.11%	(0.01) 0.11%	(-0.31) 0.12%	(-0.11) 0.39%	(0.01) 0.46%	(0.01) 0.44%	(0.01) 0.44%
Public	31.32%	26.42%	24.32%	28.18%	28.07%	28.61%	29.12%	29.47%	28.35%	28.34%	28.21%	28.91%	29.88%	29.92%	29.88%	29.80%	29.85%	34.41%	34.18%	34.11%	39.04%	39.12%
No. of Shareholders	66,647	66,791	63,915	64,381	64,921	65,574	66,159	64,603	63,537	63,975	66,116	68,959	74,003	80,953	76,291	78,634	80,838	80,116	81,038	81,039	80,195	81,475

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	4	2	3	1	2	1	2	3	1	2	2	3	4	3	3	4	4	4	4	1	2
Sales Growth % (YoY)	91%	3%	75%	-64%	85%	-38%	-34%	-16%	-73%	-8%	-18%	-30%	7%	-38.2%	-32%	272%	76%	170.5%	193.4%	-86.9%	41%
Sales Growth % (QoQ)	100%	-33.3%	200%	-50%	100%	-50%	-33.3%	200%	-50%	-	-33.3%	-25%	33.3%	-	-25%	-	-	-	300%	-50%	-
Expenses	25	18	18	19	16	16	15	16	11	9	12	11	11	34	55	26	25	24	37	29	45
Operating Profit	-21	-16	-15	-18	-14	-15	-13	-14	-10	-7	-9	-8	-7	-32	-52	-22	-21	-20	-32	-28	-43
OPM %	-588	-1066	-530	-1947	-749	-1014	-826	-530	-999	-287	-376	-264	-179	-1208	-1719	-494	-596	-467	-733	-2340	-2118
Other Income	8	7	3	4	1	1	2	4	4	4	6	13	6	6	2	0	6	0	0	0	5
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	2	2	1	1	1	1	2	1	1	2	2	2	2	2	2	2	2	1	1	1	1
Profit before tax	-16	-11	-13	-15	-15	-15	-13	-11	-8	-4	-5	3	-3	-28	-51	-23	-16	-21	-34	-28	-39
Tax %	0	0	0	0	0	0	0	0	0	-24	0	0	0	0	0	0	0	0	0	0	0
Net Profit	-16	-11	-13	-15	-15	-15	-13	-11	-8	-3	-5	3	-3	-28	-51	-23	-16	-21	-34	-28	-39
Net Profit Growth % (QoQ)	-45.5%	15.4%	13.3%	-	-	-15.4%	-18.2%	-37.5%	-166.7%	40%	-266.7%	200%	89.3%	45.1%	-121.7%	-43.8%	23.8%	38.2%	-21.4%	28.2%	-
Net Profit Growth % (YoY)	-6.7%	26.7%	-	-36.4%	-87.5%	-400%	-160%	-466.7%	-166.7%	89.3%	90.2%	113%	81.2%	-33.3%	-50%	17.9%	59%	-	-	-	-
TTM Net Profit	-55	-54	-58	-58	-54	-47	-35	-27	-13	-8	-33	-79	-105	-118	-111	-94	-99	-122	-101	-67	0
EPS in Rs	-0.61	-0.42	-0.59	-0.68	-0.68	-0.69	-0.61	-0.51	-0.35	-0.14	-0.22	0.13	-0.13	-1.27	-2.34	-1.06	-0.75	-0.95	-1.76	-1.48	-2.05

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2008	Mar 2007
Sales	7	7	12	14	12	13	13	286	625	543	499	521	117	112
Sales Growth %	6.8%	-43%	-13.7%	14.4%	-12.2%	6.8%	-95.6%	-54.3%	15.1%	8.8%	-4.2%	2.1%	4.8%	27%
Expenses	70	58	43	41	48	44	48	237	392	378	369	361	105	96
Operating Profit	-63	-52	-31	-28	-36	-30	-35	49	233	165	130	159	13	16
OPM %	-885	-778	-264	-204	-308	-226	-279	17	37	30	26	31	11	15
Other Income	14	11	29	14	5	8	14	27	23	21	19	9	3	1
Interest	0	0	0	0	1	1	1	2	5	6	6	5	5	3
Depreciation	6	6	6	7	4	4	4	11	21	21	18	12	4	4
Profit before tax	-55	-47	-9	-20	-36	-28	-26	63	230	159	126	152	6	11
Tax %	0	0	-11	0	0	-19	-47	38	31	23	20	28	-32	-5
Net Profit	-55	-47	-8	-20	-36	-23	-14	39	158	123	100	109	8	11
Net Profit Growth %	-17%	-487.5%	60%	44.4%	-56.5%	-64.3%	-135.9%	-75.3%	28.5%	23%	-8.3%	1262.5%	-27.3%	-
EPS in Rs	-2.08	-2.16	-0.37	-0.92	-1.66	-1.19	-0.72	2.05	8.3	6.47	5.24	5.7	0.48	0.65
Dividend Payout %	0	0	0	0	0	0	0	49	12	10	25	7	35	26

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2008	Mar 2007
Cash from Operating Activity	-68	-49	-21	-23	-37	-37	-45	-12	105	147	90	143	4	16
Cash from Investing Activity	-686	44	-1	-349	-107	2	42	-4	-38	-353	-62	-110	-16	-20
Cash from Financing Activity	757	-1	-1	396	146	35	4	5	-52	-30	-68	179	6	13
Net Cash Flow	3	-5	-22	24	2	1	1	-11	15	-236	-40	212	-7	8

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2008	Mar 2007
Equity Capital	26	23	22	22	22	22	15	13	13	13	13	13	13	13	12	6
Reserves	1477	259	778	171	824	832	461	389	375	389	854	719	611	547	95	96
Borrowings	17	0	0	0	1	2	3	5	6	3	34	71	83	109	55	41
Other Liabilities	11	56	9	19	5	5	7	9	16	35	114	74	68	105	38	30
Total Liabilities	1531	337	809	212	851	860	486	415	410	439	1014	876	774	773	199	173
Fixed Assets	73	58	60	25	28	37	38	21	25	22	308	306	305	172	110	96
CWIP	4	1	0	0	0	0	4	5	0	0	25	10	7	107	4	5
Investments	1094	247	714	74	653	528	426	295	242	359	381	366	23	0	2	5
Other Assets	361	32	35	113	170	295	19	95	143	58	301	195	438	494	83	68
Total Assets	1531	337	809	212	851	860	486	415	410	439	1014	876	774	773	199	173

Delivery

Delivery Data: SUVEN

#	Date	276 46% 403	Value (Cr)	Q/T 40	Del 40	Del 20
1	21-Oct	279	12	33	60	7
2	19-Oct	290	10	32	47	5
3	16-Oct	304	16	28	36	6
4	15-Oct	300	108	44	17	19
5	14-Oct	285	11	26	45	5
6	13-Oct	284	16	31	39	6
7	12-Oct	286	20	30	30	6
8	9-Oct	283	17	34	47	8
9	8-Oct	289	17	29	51	9
10	7-Oct	306	10	32	49	5
11	6-Oct	309	28	56	55	16
12	5-Oct	306	9	25	47	4
13	1-Oct	308	22	38	46	10
14	30-Sep	320	13	43	62	8
15	29-Sep	325	35	37	47	17
16	28-Sep	322	12	27	55	7
17	25-Sep	335	8	30	42	4
18	24-Sep	335	7	38	55	4
19	23-Sep	342	9	38	60	6
20	22-Sep	335	9	31	47	4
21	21-Sep	338	20	33	46	9
22	18-Sep	342	9	27	41	4
23	17-Sep	350	13	33	41	5
24	16-Sep	336	17	29	37	6
25	15-Sep	333	30	42	53	16
26	11-Sep	356	13	22	55	7
27	10-Sep	361	11	27	42	5
28	9-Sep	358	28	29	46	13
29	8-Sep	370	17	26	50	9
30	7-Sep	377	33	32	37	12
31	4-Sep	378	19	25	45	8
32	3-Sep	378	64	32	29	19
33	2-Sep	373	21	27	42	9
34	1-Sep	382	35	36	39	14
35	31-Aug	392	65	46	32	21
36	28-Aug	365	8	33	42	3
37	27-Aug	368	11	32	39	4
38	26-Aug	372	20	37	34	7
39	25-Aug	360	20	36	41	8
40	24-Aug	370	52	49	38	20
41	21-Aug	373	70	44	32	22
42	20-Aug	374	118	58	31	36
43	19-Aug	333	13	36	38	5
44	18-Aug	340	19	42	31	6
45	17-Aug	333	47	43	28	13
46	14-Aug	342	20	38	38	8
47	13-Aug	326	8	31	41	3
48	12-Aug	331	15	39	41	6

Daily Market Cap

Date	Total Market Cap	Change	Chg %
21-Oct	7,840c	369c	4.49
19-Oct	8,208c	406c	4.71
17-Oct	8,614c	0	0
16-Oct	8,614c	123c	1.45
15-Oct	8,491c	478c	5.96
14-Oct	8,014c	24c	0.30
13-Oct	8,038c	16c	0.19
12-Oct	8,053c	82c	1.03
09-Oct	7,971c	147c	1.81
08-Oct	8,118c	612c	7.01
05-Oct	8,730c	107c	1.22
01-Oct	8,837c	284c	3.11
29-Sep	9,121c	40c	0.44
28-Sep	9,082c	349c	3.70
25-Sep	9,431c	69c	0.73
24-Sep	9,500c	4c	0.04
22-Sep	9,496c	160c	1.65
17-Sep	9,655c	565c	5.53
10-Sep	10,220c	585c	5.41
07-Sep	10,805c	116c	1.08
04-Sep	10,689c	0	0

Stock Checklist

Price is above from 52 week high low average: 55%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 12 fund scheme(s) across 5 fund house(s) as of Oct26 · Total value ₹13 Cr · 4 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Motilal Oswal Mutual Fund	4	0.26%	+0.27%	12.9
Bandhan Mutual Fund	2	0.19%	+0.04%	0.1
Groww Mutual Fund	2	0.01%	+0.01%	0.1
Mirae Asset Mutual Fund	2	0.02%	+0.01%	0
Angel One Mutual Fund	2	0.02%	+0.01%	0

Suven Life Sciences Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements